Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 32 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 6063794

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted May 16, 2000 · Expires May 11, 2020

    expired
  2. US 6060310

    Transcription factor decoy and tumor growth inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2000 · Expires May 4, 2020

    expired
  3. US 6057298

    Keratin K1 expression vectors and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 2, 2000 · Expires Apr 27, 2020

    expired
  4. US 6057158

    Adenovirus vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 2, 2000 · Expires Apr 27, 2020

    expired
  5. US 6046169

    Inhibitors of factor XA

    COR Therapeutics, Inc. · Granted Apr 4, 2000 · Expires Mar 30, 2020

    expired
  6. US 6037149

    DNA encoding human asthma associated factor 1

    Magainin Pharmaceuticals Inc. · Granted Mar 14, 2000 · Expires Mar 9, 2020

    expired
  7. US 6033905

    Gibbon ape leukemia virus-based retroviral vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 7, 2000 · Expires Mar 2, 2020

    expired
  8. US 6030968

    Positive AMPA receptor modulation to enhance brain neurotrophic factor expression

    The Regents of the University of California · Granted Feb 29, 2000 · Expires Feb 24, 2020

    expired
  9. US 6022736

    Nucleic acid vectors comprising DNase I hypersensitive sites

    The Board of Regents of the University of Washington · Granted Feb 8, 2000 · Expires Feb 3, 2020

    expired
  10. US 6022861

    Ketoheterocyclic inhibitors of factor Xa

    COR Therapeutics, Inc. · Granted Feb 8, 2000 · Expires Feb 3, 2020

    expired
  11. US 6015552

    Use of nerve growth factor-2 (NGF-2) /neurotrophin-3 (NT-3) to promote leukocyte proliferation

    Takeda Chemical Industries Ltd. · Granted Jan 18, 2000 · Expires Jan 13, 2020

    expired
  12. US 6013433

    Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 11, 2000 · Expires Jan 6, 2020

    expired